The Medical University of Silesia is a university located in Katowice, Poland. The university has 10,218 students and a teaching staff of 1201, including 295 professors. There are five faculties: Medicine, Dentistry, Pharmacy, Public Health, Health Sciences.

During the past decade, Samodzielny Publiczny Szpital Kliniczny nr 7 Slaskiego Uniwersytetu Medycznego w Katowicach conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Samodzielny Publiczny Szpital Kliniczny nr 7 Slaskiego Uniwersytetu Medycznego w Katowicach" #1 sponsor was "Cubist Pharmaceuticals LLC" with 1 trials, followed by "Eisai Inc." with 1 trials sponsored, "GE Healthcare" with 1 trials sponsored, "Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany" with 1 trials sponsored and "Merck KGaA, Darmstadt, Germany" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Samodzielny Publiczny Szpital Kliniczny nr 7 Slaskiego Uniwersytetu Medycznego w Katowicach" #1 collaborator was "ABX CRO" with 1 trials as a collaborator, "AG Mednet Inc." with 1 trials as a collaborator, "Advanced Clinical, LLC" with 1 trials as a collaborator, "H2O Clinical LLC" with 1 trials as a collaborator and "ICON CEAC" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Samodzielny Publiczny Szpital Kliniczny nr 7 Slaskiego Uniwersytetu Medycznego w Katowicach" are "Multiple Sclerosis" (2 trials), "Bloodloss" (1 trials), "Heart Failure" (1 trials), "Refractory Partial Seizures" (1 trials) and "Surgical Procedures, Operative" (1 trials). Many other conditions were trialed in "Samodzielny Publiczny Szpital Kliniczny nr 7 Slaskiego Uniwersytetu Medycznego w Katowicach" in a lesser frequency.

Most popular intervention types in "Samodzielny Publiczny Szpital Kliniczny nr 7 Slaskiego Uniwersytetu Medycznego w Katowicach" are "Drug" (5 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Mavenclad®" (2 trials), "Cyklokapron(R)" (1 trials), "Ecallantide" (1 trials), "Implantable Cardioverter Defibrillator" (1 trials) and "Iobenguane I -123 Injection" (1 trials). Other intervention names were less common.

The vast majority of trials in "Samodzielny Publiczny Szpital Kliniczny nr 7 Slaskiego Uniwersytetu Medycznego w Katowicach" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Samodzielny Publiczny Szpital Kliniczny nr 7 Slaskiego Uniwersytetu Medycznego w Katowicach". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Samodzielny Publiczny Szpital Kliniczny nr 7 Slaskiego Uniwersytetu Medycznego w Katowicach, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Samodzielny Publiczny Szpital Kliniczny nr 7 Slaskiego Uniwersytetu Medycznego w Katowicach, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".